Neoplasia/BPH

	Identifying PLAU as a shared pathogenic gene in type 2 diabetes and bladder urothelial carcinoma through integrated transcriptomic analysis and machine learning for diagnostic and therapeutic value. Clin Exp Med Xin S, Li G, Yang X, Su J, Li R, Qin W, Zhang Z, Wang C, Zhu Y, Feng L, Ren S, Gao Z. PMID: 42268472 [PubMed - as supplied by publisher]
	Deep spatial proteomics reveals a suppressive immune niche linked to immune evasion in renal cell carcinoma. Cancer Drug Resist Zhang Y, Zhu Y, Liu Z, Li H, Zhong B, Cui X, Kong Y, Lu H. PMID: 42267194 [PubMed]
	Global landscape analysis of antibody-drug conjugate clinical trials for prostatic neoplasms: current status, opportunities and challenges. Front Immunol Ren S, Pan F, Jin J. PMID: 42266702 [PubMed - in process]
	The international and domestic research trends of targeted therapy in bladder cancer: a bibliometric analysis of the past three decades. Front Oncol Pan Y, Sun Y, Jiao B, Zhang Y, Zhang G. PMID: 42266656 [PubMed]
	Self-Management Experience of Chinese Patients With Nonmuscle-Invasive Bladder Cancer During Intravesical Therapy: A Qualitative Study. Cancer Nurs Deng C, Soivong P, Akkadechanunt T, Sethabouppha H. PMID: 42266078 [PubMed - as supplied by publisher]
	A Nomogram for Predicting 28-Day Mortality in Critically Ill Patients With Prostate Cancer: A Retrospective Cohort Study Based on the MIMIC-IV Database. Arch Esp Urol Yao Y, Dong J, Wang Z, Su Y. PMID: 42265963 [PubMed - in process]
	A Retrospective Follow-up Study on the Effects of Different Intravesical Treatments on Recurrence Control and Quality of Life in Patients With Non-Muscle-Invasive Bladder Cancer After Transurethral Resection of Bladder Tumour. Arch Esp Urol Liu F, Hu X, Zhu X, Han T, Feng L. PMID: 42265962 [PubMed - in process]
	Association Between Functional Multiparametric MRI Features and Tumour Immune Microenvironment Phenotypes in Prostate Cancer: A Retrospective Study. Arch Esp Urol Wang P, Wang E, Ji G, Deng H, Yuan Y, Lin X, Chen K, Xiao S, Liu F. PMID: 42265960 [PubMed - in process]
	Proton Beam Therapy in Prostate Cancer: Clinical Evidence, Controversies and Future Directions. Arch Esp Urol Gomis-Sellés E, González de Dueñas M, Meca G, García-Marqueta M, Moreno-López S, Albendea Roch J, Garrido Botella MI, Caballero B, Gómez Rivas J, Shelan M, López Campos F, Couñago F. PMID: 42265951 [PubMed - in process]
	The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study. BJU Int Cheng HH, Maxwell KN, Salari K, Cooperberg MR, Follmer K, Jeter JM, Jun G, Lee DJ, Patel HD, Schaeffer EM, Sokolova AO, Wolff EM, Lin DW. PMID: 42265755 [PubMed - as supplied by publisher]
	Response letter 'A study of oral metformin for the intravesical treatment of non-muscle-invasive bladder cancer'. BJU Int van Hattum JW, Remmelink MJ, Oddens JR, de Reijke TM, Wilmink HW. PMID: 42265552 [PubMed - as supplied by publisher]
	Optimizing testicular cancer therapy: Survivorship perspectives on reducing late toxicities without compromising outcomes. Urol Oncol Cheng KW, Castillo JK, Douglawi A, Hofmann M, Ruckle HC, Prakash G, Hu B, Alsyouf M. PMID: 42265043 [PubMed - as supplied by publisher]
	Re: Brian F. Chapin, Marc Smaldone, Amado J. Zurita, et al. A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer. Eur Urol. In Press. http://dx.doi.org/10.1016/j.eururo.2026.02.011. Eur Urol Froehner M. PMID: 42265042 [PubMed - as supplied by publisher]
	Multiscale Prediction of Tumor Micronecrosis and Progression in Clear Cell Renal Cell Carcinoma Based on Artificial Intelligence: A Multicenter Cohort Study. Acad Radiol Lv D, Li J, Wang Z, Guo Z, Fang H, Yao X, Pang L, Gao J, Zhao T, Shuang W. PMID: 42265018 [PubMed - as supplied by publisher]
	Feasibility of treating neuroendocrine prostate cancer with anti-SSTR radioligands: A systematic review of imaging and treatment studies. Semin Nucl Med Valizadeh P, Jannatdoust P, Shahgholianghahfarokhi M, Heidari P, Menda Y, Shariftabrizi A. PMID: 42264967 [PubMed - as supplied by publisher]
	Single-fraction HDR brachytherapy combined with SBRT for intermediate and high-risk prostate cancer: Oncologic and patient-reported outcomes from a prospective phase II study. Radiother Oncol Büchser D, Zaragoza L, Valverde I, Santos-Zorrozua B, Perez JF, Mascarell C, Castillo LD, Hompanera A, Espinosa JM, Cacicedo J, Gomez-Iturriaga A. PMID: 42264093 [PubMed - as supplied by publisher]
	Benefits and harms of antiresorptive therapy in men with non-metastatic prostate cancer on androgen deprivation therapy: A systematic review and meta-analysis of randomized controlled trials. Metabolism Bassatne A, El Meski N, Horanieh R, Andary F, Rhayem C, Mukherji D, Akl EA, Fuleihan GE, Chakhtoura M. PMID: 42263846 [PubMed - as supplied by publisher]
	Distinctive pattern of cancer development in kidney transplant recipients: a nationwide cohort study in South Korea. Kidney Res Clin Pract Jeon H, Song SM, Lee K, Jeon J, Shin DW, Lee JE, Huh W, Han K, Jang HR. PMID: 42263773 [PubMed - as supplied by publisher]
	Feasibility and Efficacy of Reiki Versus Massage for Cancer-Related Fatigue in Patients With Breast and Prostate Cancer Receiving Hormone Therapy. J Natl Compr Canc Netw McGuire J, Roscoe J, Reschke J, Lin PJ, Mustian K, Mattick L, Rieth K, Gilmore N, Spath K, Gada U, Peppone L. PMID: 42263755 [PubMed - as supplied by publisher]
	Neoplasms in prune belly syndrome: A novel case of early-onset metastatic bladder carcinoma and systematic review of reported tumors. J Pediatr Urol São Leão Ribeiro LC, Araujo Matalani CF, Vilares RN, Suartz CV, Cordeiro MD, Alves-Ribeiro Filho L, Nahas WC, Dénes FT, Lopes RI. PMID: 42263627 [PubMed - as supplied by publisher]

Articles 1 - 20 / 188442

Page 1 of 9423



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy